GSK (GSK) 20-F 2017 FY Annual report (foreign)

Exhibit 13.1

Section 906 Certificate

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of GlaxoSmithKline plc, a public limited company incorporated under English law (the “company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form20-F for the year ended December 31, 2017 (the “Form20-F”) of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form20-F fairly presents, in all material respects, the financial condition and results of operations of the company.

Date: March 16, 2018	/s/ Emma Walmsley
	Emma Walmsley Chief Executive Officer
Date:March 16, 2018	/s/ Simon Dingemans
	Mr Simon Dingemans Chief Financial Officer